Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Caris Mpi Inc. is currently navigating 3 pending office actions within the Medical Devices & Mechanical Engineering technology area. These matters are distributed among 3 distinct examiners, which suggests a variety of perspectives and examination styles despite the number of active cases. The portfolio spans 2 distinct art units, requiring the company to adapt its technical arguments to the specific standards of different administrative groups. This diversity in examiners and art units means that the company must customize its approach for each filing.
The busiest examiner for the company is SIMS, JASON M, who is responsible for 1 pending office action. This indicates that the workload is spread, as no examiner holds more than 1 pending office action out of the total 3. For the practitioner, this distribution means that each of the 3 pending office actions requires an independent strategy, as the 3 distinct examiners and 2 distinct art units do not provide a centralized point of contact. Success across the 2 distinct art units will depend on addressing the unique prior art and technical requirements inherent in each unit's jurisdiction. The presence of multiple examiners ensures that the company's overall patent success is not dependent on the discretion of any particular examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SIMS, JASON M | 1 | 44.4% | +21.5% |
| NGUYEN, PETER | 1 | — | — |
| BICKHAM, DAWN MARIE | 1 | 46.2% | +64.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18025877 | METASTASIS PREDICTOR | SIMS, JASON M | — |
| 17922344 | Immunotherapy Response Signature | NGUYEN, PETER | — |
| 17421653 | GENOMIC PROFILING SIMILARITY | BICKHAM, DAWN MARIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18025877 | METASTASIS PREDICTOR | SIMS, JASON M | — |
| 17421653 | GENOMIC PROFILING SIMILARITY | BICKHAM, DAWN MARIE | — |
| Art Unit | Apps |
|---|---|
| 3795 | 1 |
| 1685 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18025877 | METASTASIS PREDICTOR | SIMS, JASON M | — | §101§112 | Non-Final OA | — | Pending | Mar 10, 2023 |
| 17922344 | Immunotherapy Response Signature | NGUYEN, PETER | 3795 | §101§103§112 | Final Rejection | — | Pending | Oct 28, 2022 |
| 17421653 | GENOMIC PROFILING SIMILARITY | BICKHAM, DAWN MARIE | 1685 | §101§103 | Non-Final OA | — | Pending | Jul 08, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial